Imaging offers insight into risky behavior among preteens | Study traces brain mechanisms behind deep sleep | Study finds benefit to taking preventive aspirin at night
 
February 24, 2015
CONNECT WITH SNMMI LinkedInFacebookTwitterYoutube
SNMMI SmartBrief
News for nuclear medicine and molecular imaging professionals
SIGN UP|FORWARD|ARCHIVE|ADVERTISE

Top Story
Imaging offers insight into risky behavior among preteens
Preteens who tend to experiment with new things may have different brain processes than those who do not, according to a study to be presented at the American Academy of Neurology's annual meeting. The study examined 62 girls between 11 and 13 years of age who completed a task that assessed their tendency to experiment while under functional MRI. The study uncovered differences in brain connectivity. Understanding the variation could shed light on risky behaviors among adolescents. AuntMinnie.com (free registration) (2/24), Medical News Today (2/23)
Share: LinkedInTwitterFacebookGoogle+Email
  ADVERTISEMENT  
Is Pricing Low Your Strategy to Success? Think again.
Pricing is the heart of a business. It affects everything you do and is affected by everything you do. Economists talk of supply and demand as key factors behind pricing—successful entrepreneurs manipulate demand by making their products more desirable. These six steps will help you determine the right price for your product or service, read the article and learn how to get pricing right.

Clinical News & ResearchAdvertisement
Study traces brain mechanisms behind deep sleep
Switching on neurons in the preoptic hypothalamus of mice can bring about deep sleep, according to a study in the journal Nature Neuroscience that examined the neural pathways at work during sedation. The study could help researchers develop better sedatives and sleep drugs to induce deep sleep with fewer side effects. MedicalXpress.com/News release (2/23)
Share: LinkedInTwitterFacebookGoogle+Email
Study finds benefit to taking preventive aspirin at night
Morning platelet reactivity scores associated with aspirin taken for secondary prevention are lower when patients take the medication at night to reduce risks of stroke and heart disease, compared with a morning dose, according to a study from the Netherlands. Researchers did not find a difference in 24-hour ambulatory blood pressure rates between patients who took the aspirin in the morning or evening. The findings were published in Hypertension. MedPage Today (free registration) (2/19)
Share: LinkedInTwitterFacebookGoogle+Email
  ADVERTISEMENT  
Building Workplace Trust 2015
Interaction Associates' 6th annual research study tracking trust on the job, Building Workplace Trust, is out, and more than half of employees surveyed give their organizations low marks for trust and leadership. Yet this year's findings again point to how high trust leads to better outcomes and financial results — and even boosts innovation.

Industry ReportAdvertisement
Helius begins trial enrollment for brain stimulator device
The first three multiple sclerosis patients have been enrolled by Helius Medical Technologies in a clinical trial of its Portable Neuromodulation Stimulator system, which is intended to treat patients with neurological disorders resulting from trauma or disease. The study will determine the efficacy and safety of the device, which stimulates the tongue's cranial nerves to induce neuromodulation. FDAnews (2/23)
Share: LinkedInTwitterFacebookGoogle+Email
  ADVERTISEMENT  
How to Achieve IT Agility: A Survival Guide for IT Decision Makers
When business teams add new apps and services to already-strained networks, IT departments are accountable for making everything work. Is your team ready for this challenge? Read this eGuide to learn how IT teams are automating their networks, why they're utilizing Ethernet fabrics and SDN, and what success looks like as they regain network control and business relevance.

News from the Field
Many physicians haven't reviewed Open Payments data
Seventy-two percent of doctors surveyed by MedPanel said they are aware of the Open Payments database listing financial ties between doctors and drug and device makers, but only 46% had visited the website, and about 50% of that group visited to verify that information about them was correct. Seventy-six percent of the respondents said they did not change participation in industry activities since reporting began, but 21% said their participation had decreased. The Wall Street Journal (tiered subscription model)/Pharmalot blog (2/20)
Share: LinkedInTwitterFacebookGoogle+Email
International Developments
Switzerland, China sign deal to improve medtech collaboration
An agreement between Switzerland and China seeks to boost cooperation in the medtech field. The deal aims to prevent duplicate processes and to generate dialogue between the two countries. The deal seeks to address understanding of conformity assessment procedures and technical regulations, quick access to innovative technologies and the rapid exchange of data on emerging risks. Clinica (2/23)
Share: LinkedInTwitterFacebookGoogle+Email
Health Policy
ICD-10 acknowledgement testing continues until Oct. 1
Providers can conduct ICD-10 acknowledgement testing with Medicare contractors until the Oct. 1 transition date, and Medicare will hold virtual acknowledgement testing weeks with access to help-desk support on March 2-6 and June 1-5. Tips from the CMS for acknowledgement testing include avoiding the use of claims with future dates of service and sending realistic claims. Health Data Management (2/23)
Share: LinkedInTwitterFacebookGoogle+Email
Advancing Health Care
Evidence-based app aids in identification of patients' health issues
Mobile devices that were equipped with an evidence-based application helped clinicians detect chronic health problems, according to a Columbia University School of Nursing study. The app reminded nurses to ask certain questions, and clinicians were five times more likely to detect tobacco use, 44 times more likely to diagnose depression in adults, seven times more likely to detect obesity and four times more likely to identify depression in children with the app than without. BeckersHospitalReview.com (2/20)
Share: LinkedInTwitterFacebookGoogle+Email
From SNMMI
2015 ERF-SNMMI CMIIT Laboratory Professionals Awards application deadline is Thursday
Are you a non-PhD lab professional who has developed innovative/novel and high-impact tools, techniques, and practices in molecular imaging? We want to recognize your efforts! Consider applying to the Education and Research Foundation for Nuclear Medicine and Molecular Imaging and Society for Nuclear Medicine and Molecular Imaging's CMIIT Laboratory Professionals Award. Award recipients will receive a complimentary SNMMI 2015 Annual Meeting registration and $1,000 monetary award. Apply by Thursday.
Share: LinkedInTwitterFacebookGoogle+Email
NRU reactor extends operations until 2018
On Feb. 6, the Canadian government announced that the National Research Universal (NRU) reactor will extend operations until March 31, 2018.
Share: LinkedInTwitterFacebookGoogle+Email
SmartQuote
The best day of your life is the one on which you decide your life is your own. No apologies or excuses. No one to lean on, rely on, or blame. The gift is yours -- it is an amazing journey -- and you alone are responsible for the quality of it. This is the day your life really begins."
-- Bob Moawad,
author
Share: LinkedInTwitterFacebookGoogle+Email
Learn more about SNMMI ->SNMMI | News | Meetings | Education | Publications | Membership
The news summaries appearing in SNMMI SmartBrief are based on original information from multiple internet sources and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The items above are not selected or reviewed by SNMMI prior to publication. Questions and comments may be directed to SmartBrief at snmmi@smartbrief.com.
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
 
Editor:  Melissa Turner
Advertising:  Meryl Harold
  P: 202.407.7828
 
 

Download the SmartBrief App  iTunes / Android
iTunes  Android
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2015 SmartBrief, Inc.®
Privacy policy |  Legal Information